These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6230469)

  • 21. Cerebral amyloid angiopathy in Down's syndrome.
    Belza MG; Urich H
    Clin Neuropathol; 1986; 5(6):257-60. PubMed ID: 2949903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The relation between Down's syndrome and Alzheimer-type dementia].
    Steffelaar JW; Bots GT; Evenhuis HM
    Ned Tijdschr Geneeskd; 1988 Aug; 132(33):1516-7. PubMed ID: 2971883
    [No Abstract]   [Full Text] [Related]  

  • 23. Presenile dementia associated with unbalanced Robertsonian translocation form of Down's syndrome.
    Prasher VP
    Lancet; 1993 Sep; 342(8872):686-7. PubMed ID: 8103177
    [No Abstract]   [Full Text] [Related]  

  • 24. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
    Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
    Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome.
    Wisniewski HM; Rabe A
    Ann N Y Acad Sci; 1986; 477():247-60. PubMed ID: 2949682
    [No Abstract]   [Full Text] [Related]  

  • 26. Down's syndrome and Alzheimer's disease--what is the link?
    Barr O
    Prof Nurse; 1990 Jun; 5(9):465-8. PubMed ID: 2142307
    [No Abstract]   [Full Text] [Related]  

  • 27. Alzheimer's disease in Down's syndrome: clinicopathologic studies.
    Wisniewski KE; Dalton AJ; McLachlan C; Wen GY; Wisniewski HM
    Neurology; 1985 Jul; 35(7):957-61. PubMed ID: 3159974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alzheimer's disease and Down's syndrome: a review].
    Vicari S; Caltagirone C
    Riv Neurol; 1990; 60(4):151-9. PubMed ID: 2151240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down's syndrome and Alzheimer's disease.
    Sigal MJ; Levine N
    J Can Dent Assoc; 1993 Oct; 59(10):823-5, 829. PubMed ID: 8221282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurological complications in Down's Syndrome].
    Lev N; Melamed E
    Harefuah; 2002 Sep; 141(9):820-3, 857. PubMed ID: 12362489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.
    Blusztajn JK; Lopez Gonzalez-Coviella I; Logue M; Growdon JH; Wurtman RJ
    Brain Res; 1990 Dec; 536(1-2):240-4. PubMed ID: 2150771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's in those with Down's syndrome.
    Carson VB
    Caring; 2013 Sep; 32(7):52-3. PubMed ID: 24308164
    [No Abstract]   [Full Text] [Related]  

  • 36. Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
    Hanney M; Prasher V; Williams N; Jones EL; Aarsland D; Corbett A; Lawrence D; Yu LM; Tyrer S; Francis PT; Johnson T; Bullock R; Ballard C;
    Lancet; 2012 Feb; 379(9815):528-36. PubMed ID: 22236802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of Down's syndrome and Alzheimer's disease.
    Shamas-Ud-Din S
    Br J Psychiatry; 2002 Aug; 181():167-8; author reply 168. PubMed ID: 12151296
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dementia symptoms in Down's syndrome in a residentially treated group of mentally handicapped].
    Visser FE; Kuilman M
    Ned Tijdschr Geneeskd; 1990 Jun; 134(23):1141-5. PubMed ID: 2141386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down's syndrome and Parkinson's disease.
    Brandel JP; Marconi R; Serdaru M; Vidailhet M; Agid Y
    Neurology; 1994 Dec; 44(12):2419-20. PubMed ID: 7991152
    [No Abstract]   [Full Text] [Related]  

  • 40. Tests for genetic heterogeneity among 18 families with Alzheimer's disease.
    Marazita ML; Spence MA; Heyman A
    Neurology; 1987 Oct; 37(10):1678-9. PubMed ID: 2958722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.